Abstract

Breast milk is the primary source of nutrition and hydration for the newborn infant but also plays an important role in the child’s first immune defense. Additionally, several breast milk factors have been implicated in immune-related health outcomes later in life, including immunoglobulins, cytokines, chemokines, growth factors and, more recently, non-coding RNA (ncRNA) species. In this systematic review, we provide a comprehensive summary of the current literature on endogenous ncRNAs found in human breast milk. Thirty (30) relevant studies were identified and, whilst the majority studies focused on microRNAs (miRNAs), there is evidence that breast milk contains high quantities of RNA which also include long-coding RNAs, circular RNAs, as well as other short RNAs and fragmented tRNA and rRNAs. Among studies investigating miRNAs, miR-148a-3p, miR-30a/d-5p, miR-22-3p, miR-146b-5p, miR-200a/c-3p, and the 5p end of the let-7 miRNAs were commonly reported among the top 10 miRNAs in the cell, lipid, and skim milk fractions of breast milk. Methodological difference and small sample sizes limit the possibility of conclusively identifying which maternal and infant characteristics affect the miRNA profile. The highly expressed miRNAs were generally reported to be similar across lactational stage, milk fraction, maternal and infant characteristics, or infant growth and health. All the same, individual studies identify potential differences in miRNA expression levels which should be confirmed by future studies. Stability, uptake, and physiological functions of miRNAs were also considered in several studies. Breast milk miRNAs are relatively resistant to a range of harsh conditions and uptake experiments suggest that extracellular vesicles containing miRNAs and circular RNAs can be taken up by intestinal epithelial cells. Although the evidence regarding the functional effect of breast milk miRNAs is limited, the predicted functions range from metabolic and biosynthetic processes to signaling pathways, cellular adhesion, communication, growth, and differentiation. Finally, this systematic review highlights some of the methodological challenges and knowledge gaps which can help direct future research in this field. In particular, it is important to further investigate the bioavailability of miRNAs in different milk fractions, and to characterize other ncRNAs which are largely unstudied.Systematic Review RegistrationPROSPERO https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=138989, identifier CRD42020138989.

Highlights

  • Breast milk is the primary source of nutrition and hydration for the newborn infant and plays an important role in the child’s first immune defense (1–3)

  • This review includes 30 studies describing non-coding RNA (ncRNA) in human breast milk from lactating mothers (14, 15, 18, 19, 32–57)

  • With the exception of two studies which investigated long non-coding RNA (lncRNA) (41) and circular RNA (circRNA) (54), the primary objective of all other studies revolved around miRNAs

Read more

Summary

Introduction

Breast milk is the primary source of nutrition and hydration for the newborn infant and plays an important role in the child’s first immune defense (1–3). Several factors in the milk have potent immunological effects (4), such as maternal immune cells, secretory IgA, lysozymes and lactoferrin (1–3). These factors are transferred directly via breast milk from the mother to the infant, providing support to the naïve immune system. Plays an important role in developing the infant’s own immune system (5–7) and protective effects from breastfeeding have been implicated in several immunerelated health outcomes later in life (8, 9). This suggests that breastfeeding has immunological consequences beyond the breastfeeding period. Breast milk harbors a vast array of “non-coding” RNA species which could act as an alternate route contributing to the immune programming in infants, these molecules are far less explored than the more conventionally known breast milk components mentioned above

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.